Life ScienceCompany
Turning Point Therapeutics Ownership
Who owns Turning Point Therapeutics?
Turning Point Therapeutics is owned by Bristol-Myers Squibb and HBM Partners AG. It was acquired on June 3, 2022.
Is Turning Point Therapeutics PE-backed?
Yes. Turning Point Therapeutics is owned by private equity investors Bristol-Myers Squibb and HBM Partners AG.
Turning Point Therapeutics Business Overview
Where is Turning Point Therapeutics headquartered?
Turning Point Therapeutics is headquartered in San Diego, California.
What is Turning Point Therapeutics’ revenue?
Turning Point Therapeutics disclosed revenue of 31M USD for 2021 and 25M USD for 2020.
What sector is Turning Point Therapeutics in?
Turning Point Therapeutics is a life science company.
When was Turning Point Therapeutics founded?
Turning Point Therapeutics was founded in 2013.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 291 acquisitions of life science companies in 2022, including 36 acquisitions by private equity firms, and 255 by strategics.